We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns UK GSK Subsidiary Over cGMP Violations
FDA Warns UK GSK Subsidiary Over cGMP Violations
November 7, 2011
The FDA warned SmithKline Beecham, a UK subsidiary of GlaxoSmithKline (GSK), for inadequate aseptic procedures and other cGMP violations.